Bloomage BioTechnology Corporation Limited

Short Term Long Term Short Term Comparison Long Term Comparison
  • 688363
  • 1d1.11%
  • 1w0.06%
  • 1m-14.27%
  • 1y-51.14%
ATH
  • ATH Price$303.37
  • ATH Date2021-07-15
  • % since ATH-82.33%
  • % to ATH466.09%
ATL
  • ATL Price$53.00
  • ATL Date2024-04-12
  • % from ATL1.11%
  • Last Low Price$53
  • Last Low Date2024-04-12
  • % From Last Low1.11%
IPO
  • IPO Price$78.00
  • % Current ROI USD-31.29%
  • ATH Price$303.37
  • % ROI ATH 57,239.06%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="688363"]

Key Data [addtoany]

Current price $53.59
Sector Basic Materials
Industry Specialty Chemicals
Today's High/Low $54.43/$52.84
Volume 1,269,426.00
Previous Close $53
52 Week High/Low $110.06/$50.22
Market Cap 25,528,934,400.00
P/E Ratio 31.7365
Forward P/E 1 Yr. $41.32
Earnings Per Share(EPS) $2.52
Annualized Dividend $0.0115
$53.59
[addtoany]

Bloomage BioTechnology Corporation Limited, an investment holding company, develops, manufactures, and sells bio-chemical products in China, rest of Asia, the Americas, Europe, and internationally.
It offers sodium hyaluronic acid (HA) raw materials and end products for use in pharmaceutical, cosmetic, and health care products.
The company’s HA materials include pharmaceutical grade sodium hyaluronate under the Hyatrue name; food grade sodium hyaluronate under the HAPLEX name; cosmetic grade sodium hyaluronate under the Freda name; and Oligo HA under the Mini HA name.
Its end products comprise modified sodium hyaluronic gel for injection under the BioHyalux and Dermallure names.
The company also trades in HA end products and raw materials, cosmetic products, and medical devices.
Bloomage BioTechnology Corporation Limited was founded in 2003 and is based in Central, Hong Kong.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity